Panagora Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,220
| Closed | -$584K | – | 1540 |
|
|
2023
Q1 | $584K | Hold |
25,220
| – | – | ﹤0.01% | 1061 |
|
|
2022
Q4 | $661K | Sell |
25,220
-6,920
| -22% | -$181K | ﹤0.01% | 1052 |
|
|
2022
Q3 | $632K | Buy |
+32,140
| New | +$632K | ﹤0.01% | 1052 |
|
|
2021
Q2 | – | Sell |
-30,985
| Closed | -$482K | – | 3018 |
|
|
2021
Q1 | $482K | Sell |
30,985
-26,556
| -46% | -$413K | ﹤0.01% | 1347 |
|
|
2020
Q4 | $912K | Sell |
57,541
-2,475
| -4% | -$39.2K | 0.01% | 1009 |
|
|
2020
Q3 | $729K | Sell |
60,016
-52,752
| -47% | -$641K | ﹤0.01% | 1016 |
|
|
2020
Q2 | $1.3M | Hold |
112,768
| – | – | 0.01% | 833 |
|
|
2020
Q1 | $1.54M | Sell |
112,768
-515
| -0.5% | -$7.05K | 0.01% | 686 |
|
|
2019
Q4 | $668K | Sell |
113,283
-24,528
| -18% | -$145K | ﹤0.01% | 1201 |
|
|
2019
Q3 | $730K | Buy |
137,811
+914
| +0.7% | +$4.84K | ﹤0.01% | 1154 |
|
|
2019
Q2 | $1.05M | Buy |
136,897
+11,525
| +9% | +$88.7K | ﹤0.01% | 1117 |
|
|
2019
Q1 | $2.5M | Buy |
125,372
+103,151
| +464% | +$2.05M | 0.01% | 751 |
|
|
2018
Q4 | $293K | Buy |
22,221
+3,584
| +19% | +$47.3K | ﹤0.01% | 1499 |
|
|
2018
Q3 | $685K | Buy |
+18,637
| New | +$685K | ﹤0.01% | 1282 |
|
|
2017
Q3 | – | Sell |
-179
| Closed | -$10K | – | 2541 |
|
|
2017
Q2 | $10K | Buy |
+179
| New | +$10K | ﹤0.01% | 2442 |
|
|
2017
Q1 | – | Sell |
-488
| Closed | -$28K | – | 2463 |
|
|
2016
Q4 | $28K | Sell |
488
-79
| -14% | -$4.53K | ﹤0.01% | 2173 |
|
|
2016
Q3 | $35K | Sell |
567
-709
| -56% | -$43.8K | ﹤0.01% | 2186 |
|
|
2016
Q2 | $72K | Hold |
1,276
| – | – | ﹤0.01% | 1993 |
|
|
2016
Q1 | $82K | Buy |
+1,276
| New | +$82K | ﹤0.01% | 1909 |
|
|
2015
Q3 | – | Sell |
-820
| Closed | -$124K | – | 2457 |
|
|
2015
Q2 | $124K | Buy |
+820
| New | +$124K | ﹤0.01% | 1879 |
|